PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.

Giuseppe Lo RussoArsela PrelajJames DolezalTeresa BeninatoLuca AgnelliTiziana TriulziAlessandra FabbriDaniele LorenziniRoberto FerraraMarta BrambillaMario OcchipintiLaura MazzeoLeonardo ProvenzanoAndrea SpagnolettiGiuseppe ViscardiFrancesco SgambelluriSilvia BrichVanja MiskovicAlessandra Laura Giulia PedrocchiFrancesco Trovo'Sara ManglavitiClaudia GianiPaolo AmbrosiniRita LeporatiAndrea FranzaJohn McCullochTommaso TorelliAndrea AnichiniRoberta MortariniGiorgio TrinchieriGiancarlo PruneriValter TorriFilippo De BraudClaudia ProtoMonica GanzinelliMarina Chiara Garassino

Published in: Journal for immunotherapy of cancer (2023)

2017-002841-31.

Keyphrases

advanced non small cell lung cancer
small cell lung cancer
clinical trial
epidermal growth factor receptor
tyrosine kinase
study protocol